Oral Is the New IV. Challenging Decades of Blood and Bone Infection Dogma: A Systematic Review
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Oral Is the New IV. Challenging Decades of Blood and Bone Infection Dogma: A Systematic Review
Authors
Keywords
Bacteremia, Endocarditis, Meta-analysis, Oral antibiotics, Osteomyelitis
Journal
AMERICAN JOURNAL OF MEDICINE
Volume -, Issue -, Pages -
Publisher
Elsevier BV
Online
2021-10-27
DOI
10.1016/j.amjmed.2021.10.007
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Antibiotic Therapy for 6 or 12 Weeks for Prosthetic Joint Infection
- (2021) Louis Bernard et al. NEW ENGLAND JOURNAL OF MEDICINE
- Evaluation of a Paradigm Shift From Intravenous Antibiotics to Oral Step-Down Therapy for the Treatment of Infective Endocarditis
- (2020) Brad Spellberg et al. JAMA Internal Medicine
- Effect of C-Reactive Protein–Guided Antibiotic Treatment Duration, 7-Day Treatment, or 14-Day Treatment on 30-Day Clinical Failure Rate in Patients With Uncomplicated Gram-Negative Bacteremia
- (2020) Elodie von Dach et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Three versus six weeks of antibiotic therapy for diabetic foot osteomyelitis: A prospective, randomized, non-inferiority pilot trial
- (2020) Karim Gariani et al. CLINICAL INFECTIOUS DISEASES
- Long-Term Outcomes of Partial Oral Treatment of Endocarditis
- (2019) Henning Bundgaard et al. NEW ENGLAND JOURNAL OF MEDICINE
- Oral versus Intravenous Antibiotics for Bone and Joint Infection
- (2019) Ho-Kwong Li et al. NEW ENGLAND JOURNAL OF MEDICINE
- Four versus six weeks of antibiotic therapy for osteoarticular infections after implant removal: a randomized trial
- (2019) Mohamed Benkabouche et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Duration of Antibiotic Therapy: Shorter Is Better
- (2019) Brad Spellberg et al. ANNALS OF INTERNAL MEDICINE
- Fluoroquinolone-related adverse events resulting in health service use and costs: A systematic review
- (2019) Laura S. M. Kuula et al. PLoS One
- High-dose trimethoprim-sulfamethoxazole and clindamycin for Staphylococcus aureus endocarditis
- (2019) Hervé Tissot-Dupont et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Osteomyelitis complicating sacral pressure ulcers: whether or not to treat with antibiotic therapy
- (2018) Darren Wong et al. CLINICAL INFECTIOUS DISEASES
- Partial Oral versus Intravenous Antibiotic Treatment of Endocarditis
- (2018) Kasper Iversen et al. NEW ENGLAND JOURNAL OF MEDICINE
- Seven versus fourteen Days of Antibiotic Therapy for uncomplicated Gram-negative Bacteremia: a Non-inferiority Randomized Controlled Trial
- (2018) Dafna Yahav et al. CLINICAL INFECTIOUS DISEASES
- Short Course Antibiotic Therapy—Replacing Constantine Units with “Shorter Is Better”
- (2018) Noah Wald-Dickler et al. CLINICAL INFECTIOUS DISEASES
- Introduction, comparison, and validation of Meta-Essentials : A free and simple tool for meta-analysis
- (2017) Robert Suurmond et al. Research Synthesis Methods
- Short- versus long-duration levofloxacin plus rifampicin for acute staphylococcal prosthetic joint infection managed with implant retention: a randomised clinical trial
- (2016) Jaime Lora-Tamayo et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- The New Antibiotic Mantra—“Shorter Is Better”
- (2016) Brad Spellberg JAMA Internal Medicine
- Comparative Effectiveness of Beta-Lactams Versus Vancomycin for Treatment of Methicillin-SusceptibleStaphylococcus aureusBloodstream Infections Among 122 Hospitals
- (2015) Jennifer S. McDanel et al. CLINICAL INFECTIOUS DISEASES
- Antibiotic treatment for 6 weeks versus 12 weeks in patients with pyogenic vertebral osteomyelitis: an open-label, non-inferiority, randomised, controlled trial
- (2015) Louis Bernard et al. LANCET
- Trimethoprim-sulfamethoxazole versus vancomycin for severe infections caused by meticillin resistant Staphylococcus aureus: randomised controlled trial
- (2015) M. Paul et al. BMJ-British Medical Journal
- Trimethoprim-sulfamethoxazole versus vancomycin for severe infections caused by meticillin resistant Staphylococcus aureus: randomised controlled trial
- (2015) M. Paul et al. BMJ-British Medical Journal
- Six-Week Versus Twelve-Week Antibiotic Therapy for Nonsurgically Treated Diabetic Foot Osteomyelitis: A Multicenter Open-Label Controlled Randomized Study
- (2014) Alina Tone et al. DIABETES CARE
- Early Oral Antibiotic Switch Compared with Conventional Intravenous Antibiotic Therapy for Acute Cholangitis with Bacteremia
- (2014) Tae Young Park et al. DIGESTIVE DISEASES AND SCIENCES
- Antibiotics Versus Conservative Surgery for Treating Diabetic Foot Osteomyelitis: A Randomized Comparative Trial
- (2013) José Luis Lázaro-Martínez et al. DIABETES CARE
- A prospective, randomized, double dummy, placebo-controlled trial of oral cefditoren pivoxil 400mg once daily as switch therapy after intravenous ceftriaxone in the treatment of acute pyelonephritis
- (2012) Teerapong Monmaturapoj et al. INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
- Systemic Antibiotic Therapy for Chronic Osteomyelitis in Adults
- (2011) B. Spellberg et al. CLINICAL INFECTIOUS DISEASES
- Clindamycin vs. first-generation cephalosporins for acute osteoarticular infections of childhood-a prospective quasi-randomized controlled trial
- (2011) H. Peltola et al. CLINICAL MICROBIOLOGY AND INFECTION
- Long-Term Follow-Up Trial of Oral Rifampin-Cotrimoxazole Combination versus Intravenous Cloxacillin in Treatment of Chronic Staphylococcal Osteomyelitis
- (2009) G. Euba et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Complicated Skin and Skin‐Structure Infections and Catheter‐Related Bloodstream Infections: Noninferiority of Linezolid in a Phase 3 Study
- (2008) Mark H. Wilcox et al. CLINICAL INFECTIOUS DISEASES
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now